L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Lumos Diagnostics Holdings Ltd
ASX:LDX
Price:
0.265
AUD
12.77%
Market Closed
Market Cap:
AU$208.6m
Balance Sheet
Balance Sheet Decomposition
Lumos Diagnostics Holdings Ltd
Lumos Diagnostics Holdings Ltd
Balance Sheet Decomposition is not available for
Lumos Diagnostics Holdings Ltd
Lumos Diagnostics Holdings Ltd
Balance Sheet
Lumos Diagnostics Holdings Ltd
Lumos Diagnostics Holdings Ltd
Currency: USD
| Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
3
|
1
|
45
|
8
|
3
|
6
|
2
|
|
| Cash Equivalents |
0
|
3
|
1
|
45
|
8
|
3
|
6
|
2
|
|
| Total Receivables |
0
|
1
|
1
|
4
|
2
|
1
|
2
|
3
|
|
| Accounts Receivables |
0
|
1
|
0
|
2
|
2
|
1
|
2
|
3
|
|
| Other Receivables |
0
|
1
|
1
|
2
|
0
|
1
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
4
|
3
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
1
|
3
|
1
|
0
|
1
|
1
|
|
| Total Current Assets |
1
|
5
|
4
|
57
|
13
|
6
|
10
|
6
|
|
| PP&E Net |
0
|
1
|
5
|
15
|
11
|
9
|
8
|
6
|
|
| PP&E Gross |
0
|
1
|
5
|
15
|
11
|
9
|
8
|
6
|
|
| Accumulated Depreciation |
0
|
1
|
2
|
2
|
7
|
2
|
3
|
1
|
|
| Intangible Assets |
7
|
19
|
20
|
25
|
13
|
11
|
10
|
8
|
|
| Goodwill |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
8
N/A
|
25
+201%
|
30
+18%
|
98
+232%
|
37
-62%
|
25
-31%
|
27
+6%
|
21
-22%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
2
|
5
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
2
|
1
|
2
|
2
|
2
|
|
| Short-Term Debt |
5
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
1
|
3
|
2
|
25
|
9
|
3
|
9
|
5
|
|
| Total Current Liabilities |
6
|
3
|
5
|
33
|
13
|
8
|
13
|
9
|
|
| Long-Term Debt |
0
|
10
|
3
|
7
|
6
|
8
|
7
|
6
|
|
| Total Liabilities |
6
N/A
|
13
+145%
|
8
-41%
|
40
+401%
|
19
-52%
|
16
-16%
|
20
+24%
|
15
-26%
|
|
| Equity | |||||||||
| Common Stock |
3
|
12
|
34
|
84
|
92
|
92
|
98
|
104
|
|
| Retained Earnings |
0
|
1
|
12
|
27
|
72
|
81
|
89
|
95
|
|
| Other Equity |
0
|
0
|
0
|
1
|
2
|
2
|
2
|
3
|
|
| Total Equity |
3
N/A
|
11
+312%
|
22
+89%
|
58
+170%
|
18
-69%
|
9
-47%
|
7
-25%
|
6
-13%
|
|
| Total Liabilities & Equity |
8
N/A
|
25
+201%
|
30
+18%
|
98
+232%
|
37
-62%
|
25
-31%
|
27
+6%
|
21
-22%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
160
|
160
|
160
|
150
|
224
|
330
|
513
|
749
|
|
Switch to:
Switch to:
See Also
Discover More
